The structures of the mouse and human urocortin genes (Ucn and UCN)

Genomics

Volumn 50, Issue 1, 1998, Pages 23-33

  Zhao, Lingyun ^a   Donaldson, Cynthia J ^a   Smith, George W ^a,b   Vale, Wylie W ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UROCORTIN;

ANIMAL CELL; ARTICLE; BINDING SITE; BLOOD VESSEL PERMEABILITY; EXON; GENE ISOLATION; GENE LOCATION; GENE STRUCTURE; GENETIC ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY; TATA BOX;

ANIMALIA; RODENTIA;

EID: 0032524327     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5292     Document Type: Article

References (53)

1. Bornstein S. R., Uhlmann K., Haidan A., Ehrhart-Bornstein M., Scherbaum W. A. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: Leptin inhibits cortisol release directly. Diabetes. 46:1997;1235-1238.
2. Buckingham M. E. Muscle: The regulation of myogenesis. Curr. Opin. Genet. Dev. 4:1994;745-751.
3. Chang C.-P., Pearse R. V. II, O'Connell S., Rosenfeld M. G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron. 11:1993;1187-1195.
4. Chang L.-S., Zhao L., Zhu L., Chen M.-L., Lee M. Y. W. T. Structure of the gene for the catalytic subunit of human DNA polymerase δ (POLD1). Genomics. 28:1995;411-419.
5. Chen R., Lewis K. A., Perrin M. H., Vale W. W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA. 90:1993;8967-8971.
6. Chong J. A., Tapia-Ramirez J., Kim S., Toledo-Aral J. J., Zheng Y., Boutros M. C., Altshuller Y. M., Frohman M. A., Kraner S. D., Mandel G. REST: A mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell. 80:1995;949-957.
7. Donaldson C. J., Mathews L. S., Vale W. W. Molecular cloning and binding properties of the human type II activin receptor. Biochem. Biophys. Res. Commun. 184:1992;310-316.
8. Donaldson C. J., Sutton S. W., Perrin M. H., Corrigan A. Z., Lewis K. A., Rivier J. E., Vaughan J. M., Vale W. W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
9. Dorin R. I., Zlock D. W., Kilpatrick K. Transcriptional regulation of human corticotropin releasing factor gene expression by cyclic adenosine 3′,5′-monophosphate: Differential effects at proximal and distal promoter elements. Mol. Cell. Endocrinol. 96:1993;99-111.
10. Faisst S., Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20:1992;3-26.
11. Frohman M. A. Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: Thermal RACE. Methods Enzymol. 218:1993;340-356.
12. Heiman M. L., Ahima R. S., Craft L. S., Schoner B., Stephens T. W., Flier J. S. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology. 138:1997;3859-3863.
13. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S. T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell Biol. 14:1994;116-127.
14. Karasawa M., Zwacka R. M., Reuter A., Fink T., Hsieh C. L., Lichter P., Francke U., Weiher H. The human homolog of the glomerulosclerosis gene Mpv17: Structure and genomic organization. Hum. Mol. Genet. 2:1993;1829-1834.
15. Kishimoto T., Pearse R. V. II, Lin C. R., Rosenfeld M. G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA. 92:1995;1108-1112.
16. Kraner S. D., Chong J. A., Tsay H. J., Mandel G. Silencing the type II sodium channel gene: A model for neural-specific gene regulation. Neuron. 9:1992;37-44.
17. Li P., He X., Gerrero M. R., Mok M., Aggarwal A., Rosenfeld M. G. Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7:1993;2483-2496.
18. Liaw C. W., Lovenberg T. W., Barry G., Oltersdorf T., Grigoriadis D. E., de Souza E. B. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology. 137:1996;72-77.
19. Licinio J., Mantzoros C., Negrao A. B., Cizza G., Wong M. L., Bongiorno P. B., Chrousos G. P., Karp B., Allen C., Flier J. S., Gold P. W. Human leptin levels are pulsatile and inversely related to pituitary- adrenal function. Nat. Med. 3:1997;575-579.
20. Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA. 92:1995;836-840.
21. Lyons G. E. Vertebrate heart development. Curr. Opin. Genet. Dev. 6:1996;454-460.
22. MacDougald O. A., Lane M. D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64:1995;354-373.
23. Meyer zum Gottesberge A. M., Reuter A., Weiher H. Inner ear defect similar to Alport's syndrome in the glomerulosclerosis mouse model Mpv17. Eur. Arch. Otorhinolaryngol. 253:1996;470-474.
24. +. Neuron. 9:1992;45-54.
25. Ohshima Y., Gotoh Y. Signals for the selection of a splice site in pre-mRNA: Computer analysis of splice junction sequences and like sequences. J. Mol. Biol. 186:1987;43-51.
26. Orkin S. H. Hematopoiesis: How does it happen. Curr. Opin. Cell Biol. 7:1995;870-877.
27. Owens M. J., Nemeroff C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43:1991;425-473.
28. Parkes D. G., Vaughan J., Rivier J., Vale W., May C. N. Cardiac inotropic actions of urocortin in conscious sheep. Am. J. Physiol. 272:1997;H2115-H2122.
29. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA. 92:1995;2969-2973.
30. Perrin M. H., Donaldson C. J., Chen R., Lewis K. A., Vale W. W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology. 133:1993;3058-3061.
31. Raber J., Chen S., Mucke L., Feng L. Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects. J. Biol. Chem. 272:1997;15057-15060.
32. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
33. Sassone-Corsi P. Transcription factors responsive to cAMP. Annu. Rev. Cell Dev. Biol. 11:1995;355-377.
34. Schenkel J., Zwacka R. M., Rutenberg C., Reuter A., Waldherr R., Weiher H. Functional rescue of the glomerulosclerosis phenotype in Mpv17 mice by transgenesis with the human Mpv17 homologue. Kidney Int. 48:1995;80-84.
35. Schoenherr C. J., Anderson D. J. The neuron-restrictive silencer factor (NRSF): A coordinate repressor of multiple neuron-specific genes. Science. 267:1995;1360-1363.
36. Schoenherr C. J., Paquette A. J., Anderson D. J. Identification of potential target genes for the neuron-restrictive silencer factor. Proc. Natl. Acad. Sci. USA. 93:1996;9881-9886.
37. Schonemann M. D., Ryan A. K., McEvilly R. J., O'Connell S. M., Arias C. A., Kalla K. A., Sawchenko P. E., Rosenfeld M. G. Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 9:1995;3122-3135.
38. Schwartz M. W., Seeley R. J., Campfield L. A., Burn P., Baskin D. G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98:1996;1101-1106.
39. Seasholtz A. F., Thompson R. C., Douglass J. O. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol. Endocrinol. 2:1988;1311-1319.
40. Shibahara S., Morimoto Y., Furatani Y., Notake M., Takahashi H., Shizumu S., Horikawa S., Numa S. Isolation and sequence of the human corticotropin releasing factor precursor gene. EMBO J. 2:1983;775-779.
41. Spengler D., Rupprecht R., Van L. P., Holsboer F. Identification and characterization of a 3′,5′-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol. Endocrinol. 6:1992;1931-1941.
42. Spiegelman B. M., Flier J. S. Adipogenesis and obesity: Rounding out the big picture. Cell. 87:1996;377-389.
43. Spina M., Merlo-Pich E., Chan R. K., Basso A. M., Rivier J., Vale W., Koob G. F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564.
44. Thompson R. C., Seasholtz A. F., Herbert E. Rat corticotropin-releasing hormone gene: Sequence and tissue-specific expression. Mol. Endocrinol. 1:1987;363-370.
45. Turnbull A. V., Vale W., Rivier C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur. J. Pharmacol. 303:1996;213-216.
46. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin. Science. 213:1981;1394-1397.
47. Van L. P. Phorbolester stimulates the activity of human corticotropin-releasing hormone gene promoter via 3′,5′-cyclic adenosine monophosphate response element in transiently transfected chicken macrophages. Endocrinology. 132:1993;30-34.
48. Vaughan J., Donaldson C., Bittencourt J., Perrin M. H., Lewis K., Sutton S., Chan R., Turnbull A. V., Lovejoy D., Rivier C., Rivier J., Sawchenko P. E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
49. Vita N., Laurent P., Lefort S., Chalon P., Lelias J. M., Kaghad M., Le Fur G., Caput D., Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett. 335:1993;1-5.
50. Weiher H., Noda T., Gray D. A., Sharpe A. H., Jaenisch R. Transgenic mouse model of kidney disease: Insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome. Cell. 62:1990;425-434.
51. Wong M. L., al-Shekhlee A., Bongiorno P. B., Esposito A., Khatri P., Sternberg E. M., Gold P. W., Licinio J. Localization of urocortin messenger RNA in rat brain and pituitary. Mol. Psychiatry. 1:1996;307-312.
52. Zhao L., Chang L.-S. The human POLD1 gene: Identification of an upstream activator sequence, activation by Sp1 and Sp3, and cell cycle regulation. J. Biol. Chem. 272:1997;4869-4882.
53. Zwacka R. M., Reuter A., Pfaff E., Moll J., Gorgas K., Karasawa M., Weiher H. The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species. EMBO J. 13:1994;5129-5134.